Balyasny Asset Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
Balyasny Asset Management's NEO Position: Q3 2024 in Review
Balyasny Asset Management sold out of NeoGenomics (NEO) in Q3 2024, closing a stake of 114,512 shares — an estimated $1.59M sold.
Balyasny Asset Management first reported a position in NEO in Q1 2015 and held it in 16 quarters. The position peaked at $13.5M in Q4 2021. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.
- Balyasny Asset Management reported no remaining NeoGenomics position as of Q3 2024 after selling out during the quarter.
- Balyasny Asset Management sold 114,512 NeoGenomics shares in Q3 2024, an estimated $1.59M.
- Balyasny Asset Management first reported a position in NeoGenomics in Q1 2015 and held it in 16 quarters.
- Balyasny Asset Management's NeoGenomics position peaked at $13.5M in Q4 2021.
- 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.
Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.